X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Manufacturing and Distribution of ALCON

Yuvraj_pawp by Yuvraj_pawp
5th October 2015
in Manufacturing

What We Do
In an environment where quality and precision are critical, we employ professionals with the skills and passion to meet the expectations of our customers, as well as the regulatory bodies that govern the development and manufacturing of our eye care products.

Good Manufacturing Practices
Alcon’s Manufacturing and Technical Operations (MTO) organization is a network of nearly 14,000 individuals dedicated to producing and delivering the innovative eye care products that our customers and patients rely on. We operate 23 state-of-the art manufacturing and distribution facilities around the world, designed to ensure a reliable supply of quality eye care products.

What We Manufacture
Our manufacturing and distribution facilities are categorized by product type, dedicated to surgical equipment and devices, pharmaceuticals, and vision care products.

Surgical Devices and Equipment
Alcon manufactures technologies and devices for cataract, retinal, glaucoma and refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, like presbyopia and astigmatism. We also manufacture advanced viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery.

Pharmaceuticals
Alcon manufactures products that treat elevated intraocular pressure for people with glaucoma; products to treat eye and ear infections; and ophthalmic solutions to treat inflammation and pain associated with ocular surgery. We also manufacture eye and nasal allergy treatments, and over-the-counter dry eye relief and ocular vitamins.

Vision Care Products
At our Vision Care facilities, we manufacture daily disposable, monthly replacement and color-enhancing contact lenses. We also manufacture a complete line of contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers.

Quality and Safety Standards
Patients are at the center of everything we do and at the heart of our commitment to quality. From research and development, to manufacturing and distribution, unparalleled quality and safety standards are the keys to our success.

Alcon adheres to the strictest of regulatory and statutory requirements, while also seeking continual improvement and advancement in the way we develop and manufacture our products. This is reflected in every aspect of our business, our partner relationships and our customers’ satisfaction.

Continuous Improvement
Alcon operates a continuous improvement program that involves activities such as quality improvements and cycle-time reductions. We also make sure to maintain good manufacturing practices through consistent training of our associates in topics such as management, safety, and regulatory and technical issues.

Previous Post

Takeda to Highlight Ixazomib Clinical Development Program at Upcoming International Myeloma Workshop

Next Post

Manufracturing of Sun Pharma

Related Posts

Manufacturing

OSD Contract Manufacturing Sector Valued At $54.7bn By 2030

10th October 2022
Biden Aims To Boost US Biomanufacturing Under Chinese Threat
Manufacturing

Biden Aims To Boost US Biomanufacturing Under Chinese Threat

16th September 2022
Empowering the healthcare fraternity through dynamic online courses
Manufacturing

Empowering the healthcare fraternity through dynamic online courses

9th September 2022
CRISPR Could Overcome Gene And Cell Therapy Limitations
Drug Development

CRISPR Could Overcome Gene And Cell Therapy Limitations

29th August 2022
Moderna Announces the EC's Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19
Drug Development

Moderna Sues Pfizer, BioNTech For mRNA COVID-19 Vaccinations

29th August 2022
Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022
Manufacturing

Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022

27th August 2022
Next Post

Manufracturing of Sun Pharma

Latest News

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In